Enovis Corporation (ENOV)
- Previous Close
35.73 - Open
35.63 - Bid 31.77 x 900
- Ask 40.28 x 1100
- Day's Range
35.39 - 36.17 - 52 Week Range
29.32 - 52.76 - Volume
539,929 - Avg. Volume
1,043,877 - Market Cap (intraday)
2.06B - Beta (5Y Monthly) 1.90
- PE Ratio (TTM)
-- - EPS (TTM)
-14.64 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
56.50
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
www.enovis.comRecent News: ENOV
View MorePerformance Overview: ENOV
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENOV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENOV
View MoreValuation Measures
Market Cap
2.06B
Enterprise Value
3.48B
Trailing P/E
--
Forward P/E
11.75
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
0.79
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.65%
Return on Assets (ttm)
0.92%
Return on Equity (ttm)
-27.35%
Revenue (ttm)
2.15B
Net Income Avi to Common (ttm)
-811.94M
Diluted EPS (ttm)
-14.64
Balance Sheet and Cash Flow
Total Cash (mrq)
38.46M
Total Debt/Equity (mrq)
55.68%
Levered Free Cash Flow (ttm)
-41.37M